2395 — Shin Nippon Biomedical Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Shin Nippon Biomedical Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,142	5,250	7,287	6,997	10,533
Net Total Accounts Receivable
Net Total Receivables	1,914	2,535	2,952	3,499	4,694
Total Inventory
Total Other Current Assets
Total Current Assets	11,666	12,410	14,780	16,134	23,900
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13,687	13,700	12,898	13,156	18,879
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	54,329	39,002	36,972	39,313	57,242
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17,768	12,951	11,916	13,374	21,012
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	25,920	22,714	21,238	19,752	31,030
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	28,409	16,288	15,734	19,561	26,212
Total Liabilities & Shareholders' Equity	54,329	39,002	36,972	39,313	57,242
Total Common Shares Outstanding